Woolsey Pharmaceuticals has secured additional funds to continue advancing its ROCK inhibitor Bravyl (oral fasudil) for the ...
which has been designed to accelerate the development of treatments by testing multiple drugs for individuals with ALS. Aural Analytics also intends to develop its Speech Vitals software for other ...
Get Instant Summarized Text (Gist) The HEALEY ALS platform trials evaluated four potential ALS treatments but found none met primary or secondary endpoints. The trials demonstrated the platform's ...
Hosted on MSN27d
A step towards aphasia treatment: Study maps new brain regions behind intended speechWhile the current go-to treatment is speech ... to decode someone's intended speech. Currently, BCI devices are only used on individuals with paralysis from ALS or stroke in the brainstem, which ...
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...
While the current go-to treatment is speech ... to decode someone's intended speech. Currently, BCI devices are only used on individuals with paralysis from ALS or stroke in the brainstem, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback